Reuters -- Teva Pharmaceutical Industries, the world’s largest generic drugmaker, reported higher quarterly net profit on Tuesday, boosted by sales of its multiple sclerosis drug Copaxone and respiratory business.
Reuters -- Teva Pharmaceutical Industries, the world’s largest generic drugmaker, reported higher quarterly net profit on Tuesday, boosted by sales of its multiple sclerosis drug Copaxone and respiratory business.
